The downregulation of HPGD is associated with increased levels of PGE2 in the tumour microenvironment, leading to the increased proliferation and survival of hepatocytes, which contributes to the development of HCC from metabolic dysfunction-associated steatohepatitis (Hu et al., 2023). Here, HPGD is linked to hepatocellular carcinoma.